|
408 Dose-dense paclitaxel and carboplatin plus bevacizumab is an effective and a tolerable first-line regimen for advanced ovarian cancer |
|
|
|
Title: |
408 Dose-dense paclitaxel and carboplatin plus bevacizumab is an effective and a tolerable first-line regimen for advanced ovarian cancer |
Author: |
Komazaki, H. Takahashi, K. Tanabe, H. Shoburu, Y. Izumi, A. Kamii, M. Tsuda, A. Saito, M. Yamada, K. Takano, H. Niimi, S. Okamoto, A. |
Appeared in: |
International journal of gynecological cancer |
Paging: |
Volume 30 () nr. S3 pages A169-A170 |
Year: |
2020 |
Contents: |
|
Publisher: |
Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|